Press releases 2001
2001/043 NICE issues advice on appropriate referral from general to specialist services
20/12/2001
NICE 2001/042 Response to Drug & Therapeutics Bulletin- sibutramine
13/12/2001
2001/039 Healthcare professionals and patients to collaborate on the development
05/12/2001
2001/041 NICE response to Department of Health announcement on new statutory obligations for NHS to fund treatments recommended by NICE
05/12/2001
2001/040 NICE Response to Consumers´ Association Briefing Paper
04/12/2001
2001/038 NICE to seek advice from new Citizens Council
22/11/2001
2001/037 Appeal Period for appraisal of beta interferon and glatiramer closes
15/11/2001
2001/36A NICE moves forward with review of dissemination
06/11/2001
2001/35 Appraisal of beta interferon and glatiramer for multiple sclerosis - Final Appraisal Determination
30/10/2001
2001/034 Discussions between the Department of Health and the manufacturers of beta interferon and glatiramer for multiple sclerosis
30/10/2001
2000/33 NICE welcomes results of National Caesarean Audit to support the development of a national guideline
26/10/2001
2001/32 NICE issues guidance on sibutramine for obesity
17/10/2001
2001/31 NICE issues guidance on chemotherapy agents for breast cancer and leukaemia
25/09/2001
2001/30 NICE Board considers its response to the Kennedy Report (Bristol Enquiry)
19/09/2001
2001/29 Appraisal of Beta Interferon and Glatiramer for Multiple Sclerosis
07/08/2001
2001/28 NICE issues Guidance on Topotecan for Ovarian Cancer
06/08/2001
2001/27 NICE welcomes additional topics for Work Programme
31/07/2001
NICE 2001/26 NICE is consulting on the way forward for the Confidential Enquiries
27/07/2001
2001/025 Cox II inhibitors for osteoarthritis and rheumatoid arthritis
26/07/2001
NICE welcomes two new members of staff
23/07/2001
2001/23 Update on the Referral Practice Project
18/07/2001
NICE appoints Guidelines Programme Director
06/07/2001
2001/21 National guideline on induction of labour
12/06/2001
2001/19 Sibutramine Appraisal Update
24/05/2001
2001/17 NICE issues clinical guideline on electronic fetal monitoring
17/05/2001
2001/18 Response to BMA Survey
17/05/2001
2001/16 NICE issues guidance on gemcitabine for pancreatic cancer
08/05/2001
2001/ 15 Announcement on Sixth Work Programme Consultation
08/05/2001
2001/012 - NICE issues guidelines on heart attacks and prevention of pressure sores
30/04/2001
2001/13 NICE issues Guidance on Temozolomide for Brain Cancer
27/04/2001
2001/14 NICE issues guidance on debriding agents for difficult to heal surgical wounds
27/04/2001
2001/011 - NICE welcomes Fifth Wave Work Programme
12/03/2001
2001/010 - NICE issues guidance on Orlistat for obesity
09/03/2001
2001/ 008 - DTB Publication on zanamivir (Relenza)
15/02/2001
2001/ 006 - Board Approves New Guidance on Technology Appraisal Process
07/02/2001
2001/ 007 - NICE enhances Clinical Guidelines, PRODIGY and Audit Management Capacity
07/02/2001
2001/ 005 - Announcement on 5th Work Programme Consultation
02/02/2001
2001/ 004 - Health Technology Appraisal: beta interferons & glatiramer acetate for Multiple Sclerosis
29/01/2001
2001/ 003 - NICE issues Guidance on Riluzole for Motor Neurone Disease
17/01/2001
